PRINCETON, N.J., June 23, 2023 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today praised the Executive Order issued by President Biden that addresses barriers in access to high quality contraceptive care and family planning services....
PRINCETON, N.J., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced that Josephine Torrente has been appointed to the Company’s board of directors, as a Class II director, effective as of October 7, 2021. Ms....
PRINCETON, N.J., Nov. 18, 2014 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX) today announced that John Hubbard, Ph.D., FCP has been appointed to the Company's Board of Directors, effective November 18, 2014. Dr. Hubbard will serve on Agile's Nominating and Corporate Governance...
PRINCETON, N.J., Oct. 1, 2014 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc., (Nasdaq:AGRX) announced today that James P. Tursi, M.D. has been appointed to the Company's Board of Directors effective October 1, 2014. Dr. Tursi will serve on the Compensation Committee....
